tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market

Karyopharm Therapeutics (KPTI) Cash flow

Compare
1,163 Followers

Karyopharm Therapeutics Cash Flow

KPTI's free cash flow for Q4 2024 was $-25.76M. For the 2024 fiscal year, KPTI's free cash flow was decreased by $-34.91M and operating cash flow was $-25.81M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -127.49M$ -92.72M$ -149.55M$ -107.12M$ -160.23M
Investing Cash Flow
$ 95.47M$ 7.94M$ -104.26M$ 141.84M$ -53.69M
Financing Cash Flow
$ 41.65M$ 1.12M$ 193.74M$ 73.65M$ 172.08M
End Cash Position
$ 62.81M$ 53.19M$ 136.88M$ 197.44M$ 89.12M
Free Cash Flow
$ -127.63M$ -92.72M$ -149.67M$ -112.83M$ -160.38M
Currency in USD

Karyopharm Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis